The abstract is read at the publisher; the summary is JClub's.
FTO downregulation is linked to vascular calcification, and restoring FTO activity inhibits calcification in high phosphate–treated VSMCs and vD3-induced mouse arteries.
- Why it matters: Vascular calcification contributes to cardiovascular risk in chronic kidney disease, but how the N6-methyladenosine demethylase FTO regulates this process is unclear.
- What they did: Calcification was induced with high Pi in VSMCs and aortic rings and with high-dose vitamin D3 in mice; FTO was manipulated using adenovirus, AAV, and siRNA, with F,B-2,3 used as an inhibitor. Integrated MeRIP-seq and RNA-seq identified Pcsk9 as a potential FTO target, and NF-κB signaling and inflammatory cytokines were assessed.
- The result: FTO knockdown increased osteogenic gene expression and calcification, while FTO overexpression and F,B-2,3 treatment reduced calcification; Pcsk9 knockdown or p65 inhibition abolished FTO-silencing effects on osteogenic transition and calcification in VSMCs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.